Brief: FDA Approves New Guardant360 Liquid Cdx, The Largest FDA-Approved Liquid Biopsy Panel With A 100X Expanded Footprint
20/05/2026 13:42
May 20 (Reuters) - Guardant Health Inc GH.O: FDA APPROVES NEW GUARDANT360 LIQUID CDX, THE LARGEST FDA-APPROVED LIQUID BIOPSY PANEL WITH A 100X EXPANDED FOOTPRINT Source text: ID:nBw9W1K8Ma Further company coverage: GH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guardant Health
See all newsBrief: Guardant Health Announces Approval In Europe Of Guardant360® Cdx
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
US Health Secretary Kennedy Jr. adds eight new members to key health committee (updated)
Brief: US FDA Grants Accelerated Approval To Etcamah For Advanced Breast Cancer With ESR1 Mutation
Brief: Guardant Health To Appeal Federal District Court Judgment